Release date: 05/15/2022
Expiration date: 05/14/2023
The 1999 Institute of Medicine report To Err is Human: Building a Safer Health System brought prominence to the issue of medical error in the US. Since that time multiple activities at various levels of private and regulatory arenas have targeted identification and resolution of medical error. In 2016, researchers from Johns Hopkins University published findings from their study indicating that medical error can now be ranked as the third leading cause of death in the U.S. In 2020 most states are still mandating continuing education for licensed health care professionals. Health professionals and health systems both need ongoing education in error reduction techniques in order to create and maintain an improved culture of safety.
This educational monograph addresses the identification, reporting, monitoring and reduction of medical error. It is intended to make participants aware of the magnitude of the problem, of the many-leveled activities needed to resolve it, and the importance of each person’s role in the national effort to reduce medical errors.
This activity is intended for physicians, pharmacists, nurses, nurse practitioners, psychologists and other healthcare professionals at all levels and settings in the healthcare industry.
At the completion of this course, the learner should be able to:
- Recognize the magnitude and far reaching effects of medical error
- Categorize factors contributing to the occurrence of medical error
- Describe the healthcare professional’s role in identifying error prone situations
- Explain the importance of reporting medical error
- Specify at least two recommended practice modifications to promote safety and reduce the incidence of medical error
- Review the processes of root cause analysis and failure mode and effects analysis when analyzing error
Method of Participation
In order to receive credit, participants should read the entire monograph, complete and submit an evaluation and score at least 70% on the self-assessment test. AKH Inc. allows for one (1) re-test at no additional charge; additional re-tests must be purchased again at the full cost. Certificates will be available in the transcripts upon successful completion of the self-assessment test. If you have questions about this CE activity, please contact AKH Inc. at [email protected].
CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare. This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and CE University.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and CE University. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 2.0 contact hours.
FL Board of Pharmacy Tripartite, approval #20-608156.
Credit being awarded: 2.0 ANCC contact hours
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and CE University. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803.
This activity is approved for 2.0 contact hour(s) (which includes 0 hour(s) of pharmacology).
AKH Inc., Advancing Knowledge in Healthcare is approved as a provider of continuing education through the Florida Board of Nursing, provider #50-2560. This activity is awarded 2.0 contact hours.
Florida Board of Clinical Laboratory Personnel Provider #JP346. 2.0 contact hours.
FL Occupational Therapy
Board of Occupational Therapy Practice, Provider # 29. approved for 2.0 contact hours.
FL CSW, MFT, MHC
Florida Department of Health: BAP 30. Approved for 2.0 clock hours.
FL Physical Therapy
AKH Inc., Advancing Knowledge in Healthcare is approved as a provider of continuing education through the FL Board of Nursing. The FL Physical Therapy Board accepts this program for mandatory requirements.
Professions not specifically listed should check with their licensing or certification boards regarding acceptable continuing education credit.
Mary Kathleen Ebener PhD, RN
Dr. Ebener teaches courses in nursing, healthcare and statistical analysis. She is currently employed at, Florida State College at Jacksonville in Jacksonville, Florida as Dean of Nursing. She holds a BSN from Illinois Wesleyan University; her MSN is from Andrews University, MI; and her PhD. is from the University of Florida, Gainesville.
Dr. Ebener has no relevant financial relationships to disclose.
Staff, Planners and Reviewers
- Dorothy Caputo, MA, BSN, RN, CE Director of Accreditations/Lead Nurse Planner has no relevant financial relationships to disclose.
- Bernadette Marie Makar, MSN, APRN, BC, NP-C, Nurse Reviewer has no relevant financial relationships to disclose.
- Dorothy Duffy, PharmD – Pharmacy Reviewer has no relevant financial relationships to disclose.
- AKH and CE University have no relevant financial relationships to disclose.
There is no commercial support for this activity.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity.
Disclosure of Unlabeled Use and Investigational Products
This educational activity does not include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
AKH Inc.’s courses are designed solely to provide healthcare professionals with information to assist in their practice and professional development. The courses are researched thoroughly, utilizing current literature and including practical experiences. AKH’s courses are not to be considered a diagnostic tool to replace professional advice or treatment. The courses serve as a general guide to the healthcare professional, and therefore, they cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH educational courses do not endorse commercial products. The author(s) and the publisher specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the courses. AKH further disclaims any responsibility for undetected errors, or from the reader’s misunderstanding of the course.